TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Ireland’s Horizon Pharma Makes $3 Billion Hostile Bid for Depomed
MERGERS AND ACQUISITIONS

Ireland’s Horizon Pharma Makes $3 Billion Hostile Bid for Depomed

  • By Laura Cooper
  • Jul 7, 2015 11:52 AM EDT
Teva's Future Value Contingent on Pipeline Growth
OPINION

Big Pharma Merger Monday Deals Disregard Biotech Bubble Talks

  • By Deniel Mero
  • Mar 31, 2015 9:39 AM EDT
Stocks Inch Higher as Yellen Eases Markets Into Drop in 'Patient' Phrasing
MARKETS

Stock Markets Soar on Trifecta of Good News

  • By Keris Alison Lahiff
  • Mar 30, 2015 4:08 PM EDT
January 2 Premarket Briefing: 10 Things You Should Know
MARKETS

Energy Sector Leads Stock Markets Higher as Rally Rolls On

  • By Keris Alison Lahiff
  • Mar 30, 2015 3:31 PM EDT
Teva Buys Tourette Syndrome Drug Firm Auspex for $3.2 Billion
MERGERS AND ACQUISITIONS

Teva Buys Tourette Syndrome Drug Firm Auspex for $3.2 Billion

  • By Jonathan Braude
  • Mar 30, 2015 1:25 PM EDT
High-Yield Bond ETFs Default Wave Is Comming -- Prepare to Profit
INVESTING

Street Check: Hyperion Bought After Brean Noted Takeout Potential Last Month

  • By The Fly Staff
  • Mar 30, 2015 11:59 AM EDT
Teva Pharmaceuticals Upgraded at Mizuho
MERGERS AND ACQUISITIONS

Teva Pharmaceutical Swallows Auspex to Strengthen Its Drug Pipeline

  • By Jonathan Braude
  • Mar 30, 2015 11:44 AM EDT
Stocks Fluctuate as Oil Pares Losses, Greek Talks Continue
MARKETS

Stocks Reclaim Year-to-Date Gains as China Talks Monetary Easing

  • By Keris Alison Lahiff
  • Mar 30, 2015 11:00 AM EDT
MannKind Afrezza Contributes to Sanofi's Subpar Diabetes Unit Sales
INVESTING

Biotech Merger Monday Doesn't Squash Biotech Bubble Debate

  • By Adam Feuerstein
  • Mar 30, 2015 10:43 AM EDT
Stocks Inch Higher as Yellen Eases Markets Into Drop in 'Patient' Phrasing
MARKETS

Stock Futures Are Driving Higher Amid Big Pharma Mergers

  • By Keris Alison Lahiff
  • Mar 30, 2015 8:39 AM EDT
Don't Panic! Despite First-Quarter Fears, U.S. Economic Expansion Won't End Soon
STOCKS

March 30 Premarket Briefing: 10 Things You Should Know

  • By Nora Morrison
  • Mar 30, 2015 8:30 AM EDT
Biotech Stock Mailbag: Biogen's Alzheimer's Update, Celgene Patent Worries, Receptos, MannKind
STOCKS

Horizon Pharma Buying Orphan Drugmaker Hyperion for $1.1 Billion

  • By Adam Feuerstein
  • Mar 30, 2015 6:38 AM EDT
3 Basic Materials Stocks Driving The Sector Higher
MARKETS

Hyperion Therapeutics (HPTX) Is Strong On High Volume Today

  • By David M. Aferiat
  • Mar 27, 2015 10:04 AM EDT
Today's Weak On High Volume Stock: Ocean Rig UDW (ORIG)
MARKETS

New Lifetime High For Hyperion Therapeutics (HPTX)

  • By Jamie Hodge
  • Mar 26, 2015 1:59 PM EDT
Insider Trading Alert - RYL, BHB And AAL Traded By Insiders
MARKETS

Insider Trading Alert - HPTX, DLPH And UVE Traded By Insiders

  • By Brian Hamilton
  • Mar 11, 2015 12:47 PM EDT
3 Basic Materials Stocks Driving The Sector Higher
MARKETS

Hyperion Therapeutics (HPTX) Reaches New Lifetime High Today

  • By Jamie Hodge
  • Mar 11, 2015 9:46 AM EDT
Will Amazon.com (AMZN) Stock be Affected by New E-Book Author Royalty Plan?
MARKETS

Hyperion Therapeutics Inc (HPTX) Upgraded From Sell to Buy

  • By TheStreet Quant Ratings
  • Mar 3, 2015 11:20 AM EST
Insider Trading Alert - UVE, WETF And ENPH Traded By Insiders
MARKETS

Insider Trading Alert - PETS, HPTX And OPTT Traded By Insiders

  • By Brian Hamilton
  • Jan 23, 2015 11:00 AM EST
Continental Resources (CLR) Stock Rises Today as Oil Prices Rally
MARKETS

Hyperion Therapeutics (HPTX) Downgraded From Hold to Sell

  • By TheStreet Quant Ratings
  • Nov 14, 2014 9:37 AM EST
NewLink Genetics (NLNK) Upgraded From Sell to Hold
MARKETS

Hyperion Therapeutics (HPTX) Downgraded From Buy to Hold

  • By TheStreet Quant Ratings
  • Nov 4, 2014 9:21 AM EST
Biotech Stock Mailbag: Grading 2015 Biotech Predictions at the Halfway Point
STOCKS

Super Important Biotech and Drug Stock Events for November

  • By Adam Feuerstein
  • Nov 3, 2014 8:24 AM EST
Could This Biotech Stock Be First to Break Feuerstein-Ratain Rule?
INVESTING

Some Potential Targets for Shire to Buy With $1.6B in Free Money

  • By Adam Feuerstein
  • Oct 21, 2014 9:29 AM EDT
5 Stocks Set to Soar on Bullish Earnings
INVESTING

4 Health Care Stocks Triggering Breakout Trades on Unusual Volume

  • By Roberto Pedone
  • Sep 23, 2014 8:34 AM EDT
What to Expect When Freeport McMoRan (FCX) Reports First-Quarter Earnings Tomorrow
MARKETS

Hyperion Therapeutics (HPTX) Upgraded From Hold to Buy

  • By TheStreet Quant Ratings
  • Sep 11, 2014 8:58 AM EDT
4 Huge Stocks on Traders' Radars
INVESTING

4 Big-Volume Stocks Triggering Breakout Trades

  • By Roberto Pedone
  • Aug 14, 2014 7:00 AM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.